Vı́ctor Segarra
Vı́ctor Segarra publishes mostly in Molecular Biology, Organic Chemistry and Pharmacology, on topics such as Phosphodiesterase function and regulation, Phenothiazines and Benzothiazines Synthesis and Activities and Synthesis and Biological Evaluation.
- World rank
- #5,278,661 of 7,710,434 ranked researchers
- Rank in Spain
- #123,783 of 204,306
- Works
- 58
- Citations
- 1.2k
- Citations per work
- 21.5
What does Vı́ctor Segarra research?
Vı́ctor Segarra's work is mostly in Biochemistry, Genetics and Molecular Biology (32%), Chemistry (30%), Medicine (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1831.7%
- Physical Sciences1830.3%
- Chemistry1830.3%
- Everything else1627.0%
- Health Sciences611.0%
- Medicine611.0%
- 1Molecular Biology28% of their works
- 2Organic Chemistry26% of their works
- 3Pharmacology7% of their works
- 4Spectroscopy5% of their works
- 5Physiology4% of their works
- 6Physiology3% of their works
Research topics
- Phosphodiesterase function and regulation
- Phenothiazines and Benzothiazines Synthesis and Activities
- Synthesis and Biological Evaluation
- Asthma and respiratory diseases
- Synthesis and biological activity
- Computational Drug Discovery Methods
- Cholinesterase and Neurodegenerative Diseases
- Receptor Mechanisms and Signaling
Which keywords describe Vı́ctor Segarra's research?
The keywords of their largest research topics: Synthesis, Medicinal Chemistry, cAMP Signaling, Cyclic Nucleotide Phosphodiesterases, Anticancer Agents, Heterocyclic Compounds, Biological Activities and Phenothiazines.
- Crystal Structure
- Vascular Targeting Agents
- Molecular Docking
- Acetylcholinesterase
- Allergic Diseases
- Antimicrobial Activity
- Phenothiazines
- Heterocyclic Compounds
- cAMP Signaling
- Medicinal Chemistry
- Synthesis
- Cyclic Nucleotide Phosphodiesterases
- Anticancer Agents
- Biological Activities
- Pharmacology
- Quinoxaline
- Asthma
- Cholinesterase Inhibitors
- Tubulin Inhibitors
- Virtual Screening
- G-Protein-Coupled Receptors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Synthesis182 topics
- Medicinal Chemistry173 topics
- Cyclic Nucleotide Phosphodiesterases141 topic
- cAMP Signaling141 topic
- Anticancer Agents122 topics
- Heterocyclic Compounds122 topics
- Biological Activities111 topic
- Phenothiazines111 topic
- Pharmacology92 topics
- Antimicrobial Activity71 topic
- Quinoxaline71 topic
- Allergic Diseases61 topic
- Asthma61 topic
- Acetylcholinesterase51 topic
- Cholinesterase Inhibitors51 topic
- Molecular Docking51 topic
- Tubulin Inhibitors51 topic
- Vascular Targeting Agents51 topic
- Virtual Screening51 topic
- Crystal Structure41 topic
- G-Protein-Coupled Receptors41 topic
Where does Vı́ctor Segarra work?
Vı́ctor Segarra's main affiliation in the publication record is Almirall (Spain), Spain.
How many publications and citations does Vı́ctor Segarra have?
OpenAlex counts 58 works and 1,247 citations for Vı́ctor Segarra, an h-index of 19, ranking #5,278,661 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Vı́ctor Segarra. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.